Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation
Clinical trial NCT04332341 · RECRUITING
Trial details
- NCT number
- NCT04332341
- Sponsor
- Case Comprehensive Cancer Center
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-19
- Primary completion
- 2026-09-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.